New research reveals stem cell therapy significantly lowers heart failure risk in heart attack survivors. Patients receiving ...
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient’s own) stem cell therapy company offering VesCell™ ...
Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
Lung06 Phase 3 Trial of ENHERTU Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic NSCLC ...
In our community right now there are people who are not expecting Christmas to be very bright. They may have fallen on hard times. They may be ill, alone or ...
Travere Therapeutics, Inc. today reported its third quarter 2025 financial results and provided a corporate update. "We delivered outstanding commercial performance in the third quarter, reflecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback